Once- or twice-daily non-vitamin K antagonist oral anticoagulants in Asian patients with atrial fibrillation: A meta-analysis of randomized controlled trials

Vitamin K ◽

Meta Analysis ◽

Oral Anticoagulants ◽

Vitamin K Antagonist ◽

Controlled Trials ◽

Randomized Controlled ◽

Asian Patients

Non-vitamin K Antagonist Oral Anticoagulants and Cognitive Impairment in Atrial Fibrillation: Insights From the Meta-Analysis of Over 90,000 Patients of Randomized Controlled Trials and Real-World Studies

Frontiers in Aging Neuroscience ◽

10.3389/fnagi.2018.00258 ◽

2018 ◽

Vol 10 ◽

Cited By ~ 12

Author(s):

Chi Zhang ◽

Zhi-Chun Gu ◽

Long Shen ◽

Mang-Mang Pan ◽

Yi-Dan Yan ◽

...

Keyword(s):

Atrial Fibrillation ◽

Cognitive Impairment ◽

Vitamin K ◽

Real World ◽

Meta Analysis ◽

Oral Anticoagulants ◽

Vitamin K Antagonist ◽

Controlled Trials ◽

Standard dose versus low dose non–vitamin K antagonist oral anticoagulants in Asian patients with atrial fibrillation: A meta-analysis of contemporary randomized controlled trials

Heart Rhythm ◽

10.1016/j.hrthm.2016.09.010 ◽

2016 ◽

Vol 13 (12) ◽

pp. 2340-2347 ◽

Cited By ~ 14

Author(s):

Kang-Ling Wang ◽

Robert P. Giugliano ◽

Shinya Goto ◽

Chun-Chih Chiu ◽

Chun-Yi Lin ◽

...

Keyword(s):

Atrial Fibrillation ◽

Vitamin K ◽

Low Dose ◽

Standard Dose ◽

Meta Analysis ◽

Oral Anticoagulants ◽

Vitamin K Antagonist ◽

Controlled Trials ◽

Randomized Controlled ◽

Asian Patients

SAFETY AND EFFICACY OF NON-VITAMIN K ANTAGONIST ORAL ANTICOAGULANTS VERSUS WARFARIN IN PATIENTS UNDERGOING ATRIAL FIBRILLATION ABLATION: A META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS

Journal of the American College of Cardiology ◽

10.1016/s0735-1097(18)31020-9 ◽

2018 ◽

Vol 71 (11) ◽

pp. A479

Author(s):

Nelson Telles Garcia ◽

Khagendra Dahal ◽

Nachiket Apte ◽

Pratap Reddy ◽

Paari Dominic

Keyword(s):

Atrial Fibrillation ◽

Vitamin K ◽

Meta Analysis ◽

Oral Anticoagulants ◽

Vitamin K Antagonist ◽

Atrial Fibrillation Ablation ◽

Controlled Trials ◽

Safety And Efficacy ◽

Efficacy and safety of reduced-dose non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation: a meta-analysis of randomized controlled trials

European Heart Journal ◽

10.1093/eurheartj/ehy802 ◽

2018 ◽

Vol 40 (19) ◽

pp. 1492-1500 ◽

Cited By ~ 14

Author(s):

Kang-Ling Wang ◽

Renato D Lopes ◽

Manesh R Patel ◽

Harry R Büller ◽

Doreen Su-Yin Tan ◽

...

Keyword(s):

Atrial Fibrillation ◽

Vitamin K ◽

Meta Analysis ◽

Oral Anticoagulants ◽

Vitamin K Antagonist ◽

Controlled Trials ◽

Efficacy And Safety ◽

Reduced Dose ◽

Individual Patient Data from the Pivotal Randomized Controlled Trials of Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation (COMBINE AF): Design and Rationale

American Heart Journal ◽

10.1016/j.ahj.2020.12.002 ◽

2021 ◽

Vol 233 ◽

pp. 48-58

Author(s):

Anthony P Carnicelli ◽

Hwanhee Hong ◽

Robert P Giugliano ◽

Stuart J Connolly ◽

John Eikelboom ◽

...

Keyword(s):

Atrial Fibrillation ◽

Vitamin K ◽

Individual Patient Data ◽

Oral Anticoagulants ◽

Patient Data ◽

Vitamin K Antagonist ◽

Controlled Trials ◽

Decreased risk of renal impairment in atrial fibrillation patients receiving non-vitamin K antagonist oral anticoagulants: A pooled analysis of randomized controlled trials and real-world studies

Thrombosis Research ◽

10.1016/j.thromres.2018.12.010 ◽

2019 ◽

Vol 174 ◽

pp. 16-23 ◽

Cited By ~ 7

Author(s):

Chi Zhang ◽

Zhi-Chun Gu ◽

Zheng Ding ◽

Long Shen ◽

Mang-Mang Pan ◽

...

Keyword(s):

Atrial Fibrillation ◽

Renal Impairment ◽

Vitamin K ◽

Real World ◽

Oral Anticoagulants ◽

Pooled Analysis ◽

Vitamin K Antagonist ◽

Controlled Trials ◽

Non-vitamin K Antagonist Oral Anticoagulants vs. Warfarin at Risk of Fractures: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Frontiers in Pharmacology ◽

10.3389/fphar.2018.00348 ◽

2018 ◽

Vol 9 ◽

Cited By ~ 27

Author(s):

Zhi-Chun Gu ◽

Ling-Yun Zhou ◽

Long Shen ◽

Chi Zhang ◽

Jun Pu ◽

...

Keyword(s):

Systematic Review ◽

At Risk ◽

Vitamin K ◽

Meta Analysis ◽

Oral Anticoagulants ◽

Vitamin K Antagonist ◽

Controlled Trials ◽

Safety and efficacy of oral factor-Xa inhibitors versus Vitamin K antagonist in patients with non-valvular atrial fibrillation: Meta-analysis of phase II and III randomized controlled trials

International Journal of Cardiology ◽

10.1016/j.ijcard.2016.05.059 ◽

2016 ◽

Vol 218 ◽

pp. 235-239 ◽

Cited By ~ 2

Author(s):

Jalaj Garg ◽

Rahul Chaudhary ◽

Parasuram Krishnamoorthy ◽

Chandrasekar Palaniswamy ◽

Neeraj Shah ◽

...

Keyword(s):

Atrial Fibrillation ◽

Vitamin K ◽

Meta Analysis ◽

Factor Xa ◽

Vitamin K Antagonist ◽

Controlled Trials ◽

Safety And Efficacy ◽

Randomized Controlled ◽

Phase Ii And Iii

Faculty Opinions recommendation of Nonvitamin-K-antagonist oral anticoagulants in patients with atrial fibrillation and previous stroke or transient ischemic attack: a systematic review and meta-analysis of randomized controlled trials.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717964732.793468821 ◽

2013 ◽

Author(s):

David Kuter ◽

Rachel Rosovsky

Keyword(s):

Atrial Fibrillation ◽

Systematic Review ◽

Transient Ischemic Attack ◽

Meta Analysis ◽

Oral Anticoagulants ◽

Controlled Trials ◽

Randomized Controlled ◽

Previous Stroke ◽

Ischemic Attack

Vitamin K antagonist vs direct oral anticoagulants with antiplatelet therapy in dual or triple therapy after percutaneous coronary intervention or acute coronary syndrome in atrial fibrillation: Meta‐analysis of randomized controlled trials

Clinical Cardiology ◽

10.1002/clc.23224 ◽

2019 ◽

Vol 42 (9) ◽

pp. 839-846 ◽

Cited By ~ 1

Author(s):

Vincent Roule ◽

Pierre Ardouin ◽

Clément Briet ◽

Adrien Lemaitre ◽

Mathieu Bignon ◽

...

Keyword(s):

Atrial Fibrillation ◽

Meta Analysis ◽

Oral Anticoagulants ◽

Direct Oral Anticoagulants ◽

Coronary Intervention ◽

Vitamin K Antagonist ◽

Controlled Trials ◽

Coronary Syndrome ◽

Randomized Controlled ◽

Percutaneous Coronary